India to Kenya: Lapatinib Export Trade Route

The India to Kenya Lapatinib corridor is one of India's established pharmaceutical export routes, with 50 shipments documented worth a combined $41.0K USD. The route is dominated by ASPIDA LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 20% of all export value, reflecting the consolidated nature of India's lapatinib manufacturing sector.

Across 18 active suppliers, the average shipment value stands at $820 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with lapatinib's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 29.7%, placing it at rank #2 among India's top lapatinib export destinations globally.

On the import side, key buyers of Indian lapatinib in Kenya include TO, TO THE ORDER OF INVOICE RAISED TO:, TO THE ORDER OF - and 19 others. TO is the single largest importer with 14 shipments valued at $7.6K USD.

India's lapatinib exports to Kenya are driven primarily by a handful of large-scale manufacturers. ASPIDA LIFE SCIENCES PRIVATE LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 18 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ASPIDA LIFE SCIENCES PRIVATE LIMITED, ASPIRA BIOHEALTH LLP, R S SURGIPHARM PRIVATE LIMITED — together account for 45% of total trade value on this route. The average shipment value of $820 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medi. for human lapatinib tablets ip 250 mg 1*30 tablets, batch no- t24lt11a6 and lapatinib tablets 250mg brand : her tinib 250 tablets batch : act2408lp, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO is the largest importer with 14 shipments worth $7.6K USD — representing 18% of all lapatinib imports from India on this route. A total of 22 buyers are active on this corridor.